Stocks To Buy Now

Blog


CytRx Corp. (CYTR) to Present at the Jefferies 2015 Global Healthcare Conference

CytRx Corp., a biopharmaceutical research and development company specializing in oncology, today announced that Steven A. Kriegsman, Chairman and Chief Executive Officer, and David Haen, Vice President of Business Development and Investor Relations, will present a corporate update at the Jefferies 2015 Global Healthcare Conference on Tuesday, June 2, 2015 at 1:30 p.m. Eastern Time. The conference will take place at the Grand Hyatt in New York, NY.

A live and archived webcast of the presentation will be available on the Company’s website at www.cytrx.com/investors/presentations.

From Our Blog

Improving the Odds: How LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Is Working to Make Cancer Therapies More Effective

February 4, 2026

Despite decades of progress in oncology, many cancers remain resistant to treatment, not because therapies are unavailable, but because tumor cells adapt. Immunotherapies and chemotherapies can produce meaningful responses, yet durability and consistency remain challenges, particularly in aggressive or rare cancer subtypes. Increasingly, research is shifting toward approaches that improve how well existing treatments work, […]

Rotate your device 90° to view site.